Sutro Biopharma, Inc.
NASDAQ:STRO
3.95 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 153.731 | 67.772 | 61.88 | 42.722 | 42.736 | 38.419 | 51.741 | 59.731 |
| Cost of Revenue
| 6.816 | 8.288 | 9.773 | 76.961 | 65.612 | 54.262 | 51.897 | 43.55 |
| Gross Profit
| 146.915 | 59.484 | 52.107 | -34.239 | -22.876 | -15.843 | -0.156 | 16.181 |
| Gross Profit Ratio
| 0.956 | 0.878 | 0.842 | -0.801 | -0.535 | -0.412 | -0.003 | 0.271 |
| Reseach & Development Expenses
| 180.425 | 137.171 | 104.4 | 76.961 | 65.612 | 54.262 | 54.639 | 43.55 |
| General & Administrative Expenses
| 62.584 | 59.544 | 56.004 | 36.818 | 32.592 | 21.38 | 16.374 | 14.817 |
| Selling & Marketing Expenses
| -6.816 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 55.768 | 59.544 | 56.004 | 36.818 | 32.592 | 21.38 | 16.374 | 14.817 |
| Other Expenses
| 0 | 0 | 0 | 0 | -4.35 | 1.913 | -0.077 | 0.087 |
| Operating Expenses
| 236.193 | 196.715 | 160.404 | 113.779 | 98.204 | 75.642 | 71.013 | 58.367 |
| Operating Income
| -89.278 | -128.943 | -98.524 | -71.057 | -55.468 | -37.223 | -19.272 | 1.364 |
| Operating Income Ratio
| -0.581 | -1.903 | -1.592 | -1.663 | -1.298 | -0.969 | -0.372 | 0.023 |
| Total Other Income Expenses Net
| 0.677 | 12.239 | -7.014 | 38.929 | -0.276 | 1.913 | -0.077 | 0.087 |
| Income Before Tax
| -88.601 | -116.704 | -105.538 | -32.128 | -55.744 | -35.317 | -19.688 | 1.702 |
| Income Before Tax Ratio
| -0.576 | -1.722 | -1.706 | -0.752 | -1.304 | -0.919 | -0.381 | 0.028 |
| Income Tax Expense
| 18.192 | 2.5 | 3.137 | 4.077 | 8.679 | 3.529 | 0.535 | 0.087 |
| Net Income
| -106.793 | -119.204 | -108.675 | -36.205 | -55.744 | -35.317 | -19.688 | 1.702 |
| Net Income Ratio
| -0.695 | -1.759 | -1.756 | -0.847 | -1.304 | -0.919 | -0.381 | 0.028 |
| EPS
| -1.78 | -2.35 | -2.36 | -1.11 | -2.43 | -6.13 | -2.81 | 0.24 |
| EPS Diluted
| -1.78 | -2.35 | -2.36 | -1.11 | -2.43 | -6.13 | -2.81 | 0.24 |
| EBITDA
| -82.462 | -125.488 | -93.103 | -65.252 | -46.617 | -29.155 | -14.086 | 7.364 |
| EBITDA Ratio
| -0.536 | -1.852 | -1.505 | -1.527 | -1.091 | -0.759 | -0.272 | 0.123 |